Bolognesi_2009_Curr.Pharm.Des_15_601

Reference

Title : MTDL design strategy in the context of Alzheimer's disease: from lipocrine to memoquin and beyond - Bolognesi_2009_Curr.Pharm.Des_15_601
Author(s) : Bolognesi ML , Rosini M , Andrisano V , Bartolini M , Minarini A , Tumiatti V , Melchiorre C
Ref : Curr Pharm Des , 15 :601 , 2009
Abstract : Bolognesi_2009_Curr.Pharm.Des_15_601
ESTHER : Bolognesi_2009_Curr.Pharm.Des_15_601
PubMedSearch : Bolognesi_2009_Curr.Pharm.Des_15_601
PubMedID: 19199985

Related information

Citations formats

Bolognesi ML, Rosini M, Andrisano V, Bartolini M, Minarini A, Tumiatti V, Melchiorre C (2009)
MTDL design strategy in the context of Alzheimer's disease: from lipocrine to memoquin and beyond
Curr Pharm Des 15 :601

Bolognesi ML, Rosini M, Andrisano V, Bartolini M, Minarini A, Tumiatti V, Melchiorre C (2009)
Curr Pharm Des 15 :601